发明名称 SUBSTITUTED 1,4-DIHYDROPYRIDINE COMPOUND AS BRADYKININ ANTAGONIST
摘要 PROBLEM TO BE SOLVED: To provide a non-peptide-based antagonist of B2 receptor, having B2 antagonist activities and metabolic stability to the human liver microsome. SOLUTION: This substituted 1,4-dihydropyridine compound is a compound represented by the general formula (I) [A is independently a halogen; Y is (CH2)m, C(O) or S(O); R1 and R2 are each independently a 1-4C alkyl; R3 is a 7-9C bicycloalkyl, a 5-7C azacycloalkyl, a 7-9C azabicycloalkyl or the like; R4 is thiazolyl, imidazolyl, oxazolyl or the like; R5 is H or a 1-4C alkyl; m is 0, 1 or 2; n is 0, 1, 2, 3, 4 or 5] or a pharmaceutically acceptable salt thereof. The pharmaceutical composition contains the compound.
申请公布号 JP2001192382(A) 申请公布日期 2001.07.17
申请号 JP20000373446 申请日期 2000.12.07
申请人 PFIZER PHARMACEUTICALS INC 发明人 OKUMURA YOSHIYUKI;KAWAMURA MITSUHIRO;KAWAI MAKOTO;MURASE NORIAKI;IKEDA TAKAFUMI
分类号 A61K31/496;A61P1/16;A61P1/18;A61P3/00;A61P3/10;A61P7/00;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P13/02;A61P13/10;A61P13/12;A61P17/02;A61P17/04;A61P19/02;A61P25/06;A61P25/14;A61P25/16;A61P25/28;A61P27/02;A61P27/06;A61P27/16;A61P29/00;A61P31/12;A61P35/00;A61P37/08;A61P43/00;C07D417/06;C07D417/14;C07D451/02;C07D451/04;C07D453/02;(IPC1-7):C07D417/06 主分类号 A61K31/496
代理机构 代理人
主权项
地址